1. Home

Continuing Medical Education Information (CME)

Please Note: CME credit will be available for specific sessions occurring at the in-person event and select sessions being live streamed in real-time, and available to those participating virtually. 

Target Audience

This activity is intended for all surgeons and other healthcare professionals who are involved in the treatment of patients with cancer.

Overall Education Objectives

• Apply clinical recommendations from Annals of Surgical Oncology’s Landmark Series evidence-based guidelines to clinical practice

• Evaluate real-life patient cases, diagnoses, and treatments in breast, colorectal/gastrointestinal, endocrine/neck disease, hepato-pancreato-biliary, melanoma, peritoneal surface malignancy, and sarcoma medicine

• Implement clinical judgment skills to improve the quality of the diagnosis and treatment of patients with solid tumors

• Differentiate between various rare and common clinical problems related to surgical oncologic medicine

• Incorporate new treatment strategies for surgical oncology medicine

Accreditation

The Society of Surgical Oncology (SSO) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation

The Society of Surgical Oncology designates this live activity for a maximum of 18.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians who participate in this course virtually via live stream can earn a maximum of 15 AMA PRA Category 1 Credits™.


Disclaimer

The primary purpose of SSO 2022 is educational. Information, as well as technologies, products and/or services discussed, are intended to inform participants about the knowledge, techniques and experiences of specialists who are willing to share such information with colleagues. A diversity of professional opinions exists in the specialty and the SSO disclaims any and all liability for damages to any individual attending this conference and for all claims which may result from the use of information, technologies, products and/or services discussed at the conference.